Genetics/Genomics News

Cedars-Sinai Heart Institute researchers have received a $3 million grant from the NIH to develop a biological pacemaker that can treat patients with bradycardia.

An age- and sex-specific gene expression score calculated from the results of a blood test was a significant predictor of revascularization events in symptomatic patients without diabetes from the PROMISE trial.

Findings recently published in Nature Genetics show new gene regions found to be related to hypertension.

The past year has been a very active and exciting one in CVD and CV medicine. We have had major successes on several fronts.

Since Cardiology Today was launched 20 years ago in 1997, not only has the prognosis for patients with heart disease vastly changed, but so has the practice of cardiology.

 Cardiology Today compiled a list of the top 5 stories posted to Healio.com/Cardiology in December.

Researchers found that genetically lowered lipoprotein(a) levels are associated with decreased risk for various atherosclerosis-related diseases, indicating that pharmacological lowering of plasma Lp(a) may lower risk for peripheral vascular disease, stroke, HF and aortic stenosis, as well as CHD.

Variants of the PCSK9 and HMGCR genes linked to lower LDL were associated with protection from CV events and increased risk for diabetes in certain populations, according to findings published in The New England Journal of Medicine.

NEW ORLEANS — Despite altering lipid metabolism, a loss-of-function variant of the CETP gene did not affect risk for occlusive CVD, ischemic stroke or major coronary events, according to a presentation at the American Heart Association Scientific Sessions.